A. Symons

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia

S. Engelborghs, P. Mariën, P. D. De Deyn, 2004, International journal of geriatric psychiatry.

Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.

C. van Broeckhoven, S. Engelborghs, P. Mariën, 2006, Neurobiology of aging.

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program

C. Sindic, J. Debruyne, M. D'hooghe, 2014, Acta Neurologica Belgica.

Neuropsychiatric symptoms of dementia: cross‐sectional analysis from a prospective, longitudinal Belgian study

S. Engelborghs, P. Mariën, G. Nagels, 2005, International journal of geriatric psychiatry.

Dose dependent effect of APOE ɛ4 on behavioral symptoms in frontal lobe dementia

P. Deyn, C. Broeckhoven, S. Engelborghs, 2006, Neurobiology of Aging.

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program

C. Sindic, J. Debruyne, M. D'hooghe, 2014, Acta Neurologica Belgica.

Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia

S. Engelborghs, P. Mariën, B. Pickut, 2004, International journal of geriatric psychiatry.